Provided by Tiger Fintech (Singapore) Pte. Ltd.

IN8bio, Inc.

4.17
+0.567015.74%
Post-market: 3.79-0.3800-9.11%19:59 EDT
Volume:527.94K
Turnover:1.80M
Market Cap:12.62M
PE:-0.32
High:4.17
Open:3.58
Low:2.85
Close:3.60
Loading ...

IN8bio Inc trading halted, news pending

TIPRANKS
·
Yesterday

IN8bio Inc - Reverse Stock Split Effective June 5, 2025 - SEC Filing

THOMSON REUTERS
·
04 Jun

IN8BIO Inc. Announces 1-for-30 Reverse Stock Split Effective June 5, 2025

Reuters
·
04 Jun

IN8BIO Inc. Publishes Presentation on Harnessing Gamma-Delta T Cell Therapies for Oncology and Autoimmune Diseases

Reuters
·
04 Jun

IN8bio’s Promising Clinical Trial Results and Strategic Developments Justify Buy Rating

TIPRANKS
·
02 Jun

IN8BIO Inc. Unveils Presentation on Harnessing the Power of Gamma-Delta T Cells for Cancer Treatment

Reuters
·
02 Jun

BRIEF-In8bio Presents Positive Phase 1 Data Of Inb-200 In Newly Diagnosed Gbm Demonstrating Prolonged Progression-Free Survival

Reuters
·
02 Jun

IN8bio presents Phase 1 data on INB-200 in newly diagnosed GBM

TIPRANKS
·
02 Jun

IN8bio Inc - Inb-200 Is Well-Tolerated, Shows No Serious Toxicities Beyond Chemotherapy

THOMSON REUTERS
·
02 Jun

IN8bio Presents Positive Phase 1 Data of Inb-200 in Newly Diagnosed GBM Demonstrating Prolonged Progression-Free Survival

THOMSON REUTERS
·
02 Jun

Mizuho Securities Sticks to Their Buy Rating for IN8bio (INAB)

TIPRANKS
·
09 May

IN8bio’s Strategic Growth and Development: Buy Rating Affirmed by Soumit Roy

TIPRANKS
·
09 May

Promising Developments and Financial Stability Support Buy Rating for IN8bio

TIPRANKS
·
08 May

IN8bio Q1 EPS $(0.07), Inline

Benzinga
·
08 May

IN8BIO Reports Q1 2025 Net Loss of $5.6M, EPS Improves to $0.07 Loss from $0.20, Cash Position at $11.9M

Reuters
·
08 May

IN8bio Q1 Basic EPS USD -0.07

THOMSON REUTERS
·
08 May

IN8bio Q1 Net Income USD -5.55 Million

THOMSON REUTERS
·
08 May

Press Release: IN8bio Reports First Quarter 2025 Financial Results and Recent Business Highlights

Dow Jones
·
08 May

IN8bio to Present Clinical and Preclinical Data from Gamma-Delta T Cell Platform at Upcoming Scientific Conferences

GlobeNewswire
·
29 Apr

IN8bio Unveils Promising New Data from Next Generation Gamma-Delta T Cell Engager (TCE) Platform at AACR 2025

GlobeNewswire
·
28 Apr